Comparative analysis of the results of morphological examination of hyperplastic prostate tissue in patients with and without testosterone deficiency
- Authors: Ibishev K.S.1, Lemeshko S.I.2, Uzhakhov M.M.1, Kogan M.I.1
-
Affiliations:
- Rostov State Medical University
- Health Clinical and Diagnostic Centre
- Issue: No 4 (2025)
- Pages: 26-30
- Section: ORIGINAL ARTICLES
- URL: https://journals.rcsi.science/1728-2985/article/view/316543
- DOI: https://doi.org/10.18565/urology.2025.4.26-30
- ID: 316543
Cite item
Abstract
Introduction. Benign prostatic hyperplasia (BPH) is an important and urgent public health problem. Prostatic hyperplasia is characterized by epithelial, stromal, and muscular proliferation.
Objective. To conduct a comparative analysis of the results of morphological examination of resected prostate tissue in patients with prostatic hyperplasia with and without testosterone deficiency.
Materials and Methods. The results of morphological examination of the resected prostate tissue of 188 men with BPH were analyzed, who were divided into two groups: Group I – 71 patients with testosterone deficiency, group II (control) – 117 patients with testosterone levels above 12.1 nmol/L.
Results. In patients with testosterone deficiency, during morphological examination of resected pancreatic tissue samples, prostate hyperplasia had a diffuse stromal character, combined with cystic deformity of the acinuses, with flattened and unclassifying epithelium, against the background of basal cell hyperplasia. In patients with normal Tc levels during morphological examination, during morphological examination of resected pancreatic tissue samples, the hyperplasia in all patients was glandular (epithelial), and the epithelial cells of the acinuses were tall cylindrical, with signs of active secretion.
Conclusion. In hypogonadal men, stromal hyperplasia was detected in most cases (76.1%) in the resected prostate tissue, and in normogonadal patients, hyperplasia was glandular in all cases.
Full Text
##article.viewOnOriginalSite##About the authors
Khalid S. Ibishev
Rostov State Medical University
Author for correspondence.
Email: ibishev22@mail.ru
ORCID iD: 0000-0002-2954-842X
Dr. Sc. (Med.), Professor at the Department of Urology and Human Reproductive Health (with a Course of Pediatric Urology and Andrology)
Russian Federation, 29, Nakhichevansky Lane, Rostov-on-Don, 344022Svetlana I. Lemeshko
Health Clinical and Diagnostic Centre
Email: lemeshko_lana@mail.ru
ORCID iD: 0009-0003-0431-7902
Cand. Sc. (Med.), Morphologist
Russian Federation, 70/3, Dolomanovsky Lane, Rostov-on-Don, 344011Magomed-Khadzhi M. Uzhakhov
Rostov State Medical University
Email: magamaas@mail.ru
ORCID iD: 0000-0001-7912-2649
Postgraduate Student at the Department of Urology and Human Reproductive Health (with a Course of Pediatric Urology and Andrology)
Russian Federation, 29, Nakhichevansky Lane, Rostov-on-Don, 344022Mikhail I. Kogan
Rostov State Medical University
Email: dept_kogan@mail.ru
ORCID iD: 0000-0002-1710-0169
Honored Scientist of the Russian Federation, Dr. Sc. (Med.), Professor, Head of the Department of Urology and Human Reproductive Health (with a Course of Pediatric Urology and Andrology)
Russian Federation, 29, Nakhichevansky Lane, Rostov-on-Don, 344022References
- Pushkar D.Yu., Rasner P.I., Aboyan I.A. , Asfandiyarov F.R., Kotov S.V., Kogan M.I., Korneev I.A. , Medvedev V.L. , Neymark A.I., Novikov A.I., Pavlov V.N., Tsukanov A.Y. , Shabalkin S.A. , Shormanov I.S. LUTS/BPH – who treats? Urologiia. 2019;1:5–15. Russian (Пушкарь Д.Ю., Раснер П.И., Абоян И.А., Асфандияров Ф.Р., Котов С.В., Коган М.И., Корнеев И.А., Медведев В.Л., Неймарк А.И., Новиков А.И., Павлов В.Н., Цуканов А.Ю., Шабалкин С.А., Шорманов И.С. СНМП/ДГПЖ – кто лечит?». Урология. 2019;1:5–15.) https://dx.doi.org/10.18565/urology.2019.16.5-15
- Loran O.B., Zhiborev A.B., Gerasimenko M.Ju., Luk’janov I.V., Zajceva T.N., Evstigneeva I.S. Complex treatment of patients with benign prostatic hyperplasia. Physiotherapy, balneology and rehabilitation. 2024;23(3):135–152. Russian (Лоран О.Б., Жиборев А.Б., Герасименко М.Ю., Лукьянов И.В., Зайцева Т.Н., Евстигнеева И.С. Комплексное лечение больных доброкачественной гиперплазией предстательной железы. Физиотерапия, бальнеология и реабилитация. 2024;3(3):135–152.) https://doi.org/10.17816/rjpbr627525
- Kogan M.I., Avadieva N.E., Gevorkyan L.S., Loginov Yu.A., Metelkin A.M., Mitin A.A., Patrikeev A.А. Results of a multicenter prospective comparative study of Androgel® in men with endogenous testosterone deficiency and lower urinary tract symptoms in benign prostatic hyperplasia (POTOK). Urologiia 2023;2:32–40. Russian (Коган М.И., Авадиева Н.Э., Геворкян Л.С., Логинов Ю.А., Метелкин А.М., Митин А.А., Патрикеев А.А. Результаты многоцентрового проспективного сравнительного исследования препарата Андрогель® у мужчин с недостаточностью эндогенного тестостерона и симптомами нижних мочевыводящих путей при доброкачественной гиперплазии предстательной железы («ПОТОК»). Урология. 2023;2:32–40. https://dx.doi.org/10.18565/urology.2023.2.32-40
- Ibishev Kh.S., Krainy P.A., Mitusov V.V. et al. Comparative analysis of the effectiveness of treatment of lower urinary tract symptoms in prostate hyperplasia associated with chronic inflammation in prostate tissue when using Serenoa repens in combination with Urtica dioiccus. Urologiia. 2019;1:40–46. Russian (Ибишев Х.С., Крайний П.А., Митусов В.В. и др. Сравнительный анализ эффективности лечения симптомов нижних мочевыводящих путей при гиперплазии предстательной железы, ассоциированной с хроническим воспалением в ткани простаты, при применении Serenoa repens в комбинации с Urtica dioiccus. Урология. 2019;1:40–46.) https://dx.doi.org/10.18565/urology.2019.16.40-46
- Shormanov I.S., Kulikov S.V., Solovyov A.S., Zhigalov S.A. Features of histo- and angioarchitectonics of the prostate during the progression of BPH and the development of its complications. Urologiia. 2024;5:39–45. Russian (Шорманов И.С., Куликов С.В., Соловьев А.С., Жигалов С.А. Особенности гисто- и ангиоархитектоники простаты в ходе прогрессирования ДГПЖ и развития ее осложнений. Урология. 2024;5:39–45) https://dx.doi.org/10.18565/urology.2024.5.39-45
- Devlin C.M., Simms M.S., Maitland N.J. Benign prostatic hyperplasia – what do we know? BJU Int. 2021;127(4):389–399. doi: 10.1111/bju.15229. Epub 2020 Sep 24. PMID: 32893964.
- Cannarella R., Condorelli R.A., Barbagallo F., La Vignera S., Calogero A.E. Endocrinology of the Aging Prostate: Current Concepts. Front Endocrinol (Lausanne). 2021 Feb 22;12:554078. doi: 10.3389/fendo.2021.554078. PMID: 33692752; PMCID: PMC7939072.
- Rastrelli G., Cipriani S., Lotti F., Cellai I., Comeglio P., Filippi S., Boddi V., Della Camera P.A., Santi R., Boni L., Nesi G., Serni S., Gacci M., Maggi M., Vignozzi L. Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial. J Endocrinol Invest. 2022;45(7):1413-1425. doi: 10.1007/s40618-022-01776-9. Epub 2022 Mar 17. PMID: 35298833; PMCID: PMC9184417.
- Aboyan I.A., Tolmachev A.N., Lemeshko S.I. Morphological characteristics of hyperplastic prostate gland tissue in chronic prostatitis. Experimental and Clinical Urology. 2020(4):82–88. Russian (Абоян И.А., Толмачев А.Н., Лемешко С.И. Морфологическая характеристика ткани гиперплазированной предстательной железы при хроническом простатите. Экспериментальная и клиническая урология. 2020;4:82–88) https://doi.org/10.29188/2222-8543-2020-13-4-82-88
- Ibishev Kh.S., Khripun I.A., Gusova Z.R. et al. The problem of testosterone deficiency and erectile dysfunction in men (literature review). Urologiia. 2014;6:104–107. Russian (Ибишев Х.С., Хрипун И.А., Гусова З.Р. и др. Проблема дефицита тестостерона и эректильной дисфункции у мужчин (обзор литературы). Урология. 2014;6:104–107).
- Nicholson T.M., Ricke W.A. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 2011;82(4-5):184-99. doi: 10.1016/j.diff.2011.04.006. Epub 2011 May 26. PMID: 21620560; PMCID: PMC3179830.
- Corona G., Vignozzi L., Rastrelli G., Lotti F., Cipriani S., Maggi M. Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int. J. Endocrinol. 2014;2014:329456. doi: 10.1155/2014/329456. Epub 2014 Feb 13. PMID: 24688539; PMCID: PMC3943333.
- Corona G., Vignozzi L., Sforza A., Maggi M. Risks and benefits of late onset hypogonadism treatment: an expert opinion. World J. Mens Health. 2013;31(2):103–25. doi: 10.5534/wjmh.2013.31.2.103. Epub 2013 Aug 31. PMID: 24044106; PMCID: PMC3770846.
- Vignozzi L., Rastrelli G., Corona G, Gacci M., Forti G., Maggi M. Benign prostatic hyperplasia: a new metabolic disease? J. Endocrinol Invest. 2014;37(4):313–22. doi: 10.1007/s40618-014-0051-3. Epub 2014 Jan 24. PMID: 24458832.
- Jarvis T.R., Chughtai B., Kaplan S.A. Testosterone and benign prostatic hyperplasia. Asian J. Androl. 2015;17(2):212–16. doi: 10.4103/1008-682X.140966. PMID: 25337
Supplementary files
